News & Events

    • The Department of Haematology expanded its clinical and research services with the inauguration of the New Haematology building by Ho'nble Chief Minister of the state on 16th October 2018, comprising of 30 bed indoor unit (Acute Leukemia Ward), 09 bed state-of-art Bone Marrow Transplant unit and Stem Cell Research Centre (SCRC).

    • The MoU was signed between the Coal India Limited (CIL)-Ministry of Health & Family Welfare (MoH&FW) -SGPGIMS on 5th December 2018 for providing financial aid of Rs 10 Lakhs/ patient for Allogenic Bone Marrow Transplant of thalassemia patients. Under this MoU, the department of Haematology performed its first successful Allogenic BMT on 8th May 2019 and became the first centre in the state to have achieved this rare feat in public sector.

    • Dr SoniyaNityanand, Professor & Head, Department of Hematology took charge as State Nodal Officer (Uttar Pradesh) on 28th April 2019 for the Hemophilia Control Program under National Health Mission (NHM). Under this NHM program, free factor replacement therapy is being provided to all hemophilia patients across the state at 26 district hemophilia treatment centres.

    • The department is now one of the major referral centre in the state for the diagnosis and management of coagulation disorders. A workshop for the lab diagnosis of coagulation disorder, under the aegis of NHM, and in association with World Federation of Hemophilia (WFH) was conducted on 25th-27th July 2019 in the department.

    • The department has got the diagnostic facility of carrying out cytogenetic testing, including karyotypoing and Fluorescence in-situ hybridization (FISH), in the patients suffering from haematological malignancies.

    • The department expanded its services for providing free treatment to thalassemia patients under NHM sponsored program in form of transfusion support and chelation therapy.

    Stem Cell Research Center

    The new faculties at SCRC were recruited in 2018 to strengthen and initiate research and academic programs. The vision of SCRC is to conduct theme-based cutting edge research in basic and translational area of stem cell biology through in-vitro lab studies; preclinical and clinical trials to develop stem cell based new diagnostic and therapeutic modalities for hematological and other disease. The research areas includes understanding of basic biology of adult, multipotent and pluripotent stem cells utilizing the tools of genomics proteomics and epigenetics; development of animal models of diseases as pre-clinical platforms; modeling human diseases by Induced pluripotent stem cells (iPSCs); development of cancer stem cell based novel diagnostic and therapeutic tools and generation of CAR-T Cell for therapeutic use to cure B-ALL and other leukemia’s.